SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-026826
Filing Date
2017-05-12
Accepted
2017-05-12 14:51:47
Documents
1
Period of Report
2017-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 v466930_form4.html 4  
1 FORM 4 v466930_form4.xml 4 4165
  Complete submission text file 0001144204-17-026826.txt   5608
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 135 BEAVER STREET C/O INTERLEUKIN GENETICS, INC. WALTHAM MA 02453
Business Address
Toutain Stephan (Reporting) CIK: 0001681658 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32715 | Film No.: 17838018